| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 84501-68-8 | 4-[[1-[(4-氟苯基)甲基]-1H-苯并咪唑-2-基]氨基]哌啶-1-甲酸乙酯 | Ethyl 4-[[1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-yl]amino]piperidine-1-carboxylate |  | C22H25FN4O2 | 詳情 | 供應商 |
| 437996-53-7 | 4(3H)-Quinazolinone,2-[3-[4-(4-fluorophenyl)-1-piperazinyl]propyl]-8-methoxy-; 4(1H)-Quinazolinone,2-[3-[4-(4-fluorophenyl)-1-piperazinyl]propyl]-8-methoxy- (9CI) |  | C22H25FN4O2 | 詳情 | 供應商 | |
| 356068-94-5 | (Z)-5-(5-Fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidenemethyl)-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]; (Z)-5-(5-Fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidenemethyl)-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide; SU-11654; Toceranib; (Z)-5-[(5-Fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide; 1H-Pyrrole-3-carboxaMide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)Methyl]-2,4-diMethyl-N-[2-(1-pyrrolidinyl)ethyl]- |  | C22H25FN4O2 | 詳情 | 供應商 |